Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL)

BACKGROUND: Most pancreatic cancer patients present with advanced stage at diagnosis with extremely short expected survival and few treatment options. A multimodal palliative approach is necessary for symptom relief and optimisation of health-related quality of life. In a recent open-label trial of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wode, Kathrin, Hök Nordberg, Johanna, Kienle, Gunver S., Elander, Nils O., Bernhardson, Britt-Marie, Sunde, Berit, Sharp, Lena, Henriksson, Roger, Fransson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488501/
https://www.ncbi.nlm.nih.gov/pubmed/32917288
http://dx.doi.org/10.1186/s13063-020-04581-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488501/
https://www.ncbi.nlm.nih.gov/pubmed/32917288
http://dx.doi.org/10.1186/s13063-020-04581-y

Ejemplares similares